 | • レポートコード：D0GIR-01503 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、旅行者下痢治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。旅行者下痢治療の種類別市場規模（予防接種、非抗生物質剤、抗生物質、抗運動剤、その他）、用途別市場規模（大人旅行者下痢、子供旅行者下痢）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Salix Pharmaceuticals、Livzon、Otsuka Pharma、P&G、PaxVax、Johnson & Johnson、Shanghai United Cell、Valneva、Immuron ・地域別グローバル市場分析 2015年-2020年 ・旅行者下痢治療の北米市場（アメリカ、カナダ、メキシコ） ・旅行者下痢治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・旅行者下痢治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・旅行者下痢治療の南米市場（ブラジル、アルゼンチン） ・旅行者下痢治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：予防接種、非抗生物質剤、抗生物質、抗運動剤、その他 ・用途別分析：大人旅行者下痢、子供旅行者下痢 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Traveler’s Diarrhea Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Traveler’s Diarrhea Treatment sales will be xx in 2020 from Traveler’s Diarrhea Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Traveler’s Diarrhea Treatment market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Traveler’s Diarrhea Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Traveler’s Diarrhea Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Traveler’s Diarrhea Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Traveler’s Diarrhea Treatment market has been segmented into:
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other
By Application, Traveler’s Diarrhea Treatment has been segmented into:
Adult Traveler’s Diarrhea
Children Traveler’s Diarrhea
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Traveler’s Diarrhea Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Traveler’s Diarrhea Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Traveler’s Diarrhea Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Traveler’s Diarrhea Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Traveler’s Diarrhea Treatment Market Share Analysis
Traveler’s Diarrhea Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Traveler’s Diarrhea Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Traveler’s Diarrhea Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Traveler’s Diarrhea Treatment are:
Salix Pharmaceuticals
Livzon
Otsuka Pharma
P&G
PaxVax
Johnson & Johnson
Shanghai United Cell
Valneva
Immuron
Among other players domestic and global, Traveler’s Diarrhea Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Traveler’s Diarrhea Treatment Market Overview
1.1 Product Overview and Scope of Traveler’s Diarrhea Treatment
1.2 Classification of Traveler’s Diarrhea Treatment by Type
1.2.1 Global Traveler’s Diarrhea Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Traveler’s Diarrhea Treatment Revenue Market Share by Type in 2019
1.2.3 Immunization
1.2.4 Non-antibiotic Agents
1.2.5 Antibiotics
1.2.6 Anti-Motility Agents
1.2.7 Other
1.3 Global Traveler’s Diarrhea Treatment Market by Application
1.3.1 Overview: Global Traveler’s Diarrhea Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adult Traveler’s Diarrhea
1.3.3 Children Traveler’s Diarrhea
1.4 Global Traveler’s Diarrhea Treatment Market by Regions
1.4.1 Global Traveler’s Diarrhea Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Traveler’s Diarrhea Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Traveler’s Diarrhea Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Traveler’s Diarrhea Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Traveler’s Diarrhea Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Traveler’s Diarrhea Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Traveler’s Diarrhea Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Traveler’s Diarrhea Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the Traveler’s Diarrhea Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Traveler’s Diarrhea Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Salix Pharmaceuticals
2.1.1 Salix Pharmaceuticals Details
2.1.2 Salix Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Salix Pharmaceuticals SWOT Analysis
2.1.4 Salix Pharmaceuticals Product and Services
2.1.5 Salix Pharmaceuticals Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Livzon
2.2.1 Livzon Details
2.2.2 Livzon Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Livzon SWOT Analysis
2.2.4 Livzon Product and Services
2.2.5 Livzon Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Otsuka Pharma
2.3.1 Otsuka Pharma Details
2.3.2 Otsuka Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Otsuka Pharma SWOT Analysis
2.3.4 Otsuka Pharma Product and Services
2.3.5 Otsuka Pharma Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 P&G
2.4.1 P&G Details
2.4.2 P&G Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 P&G SWOT Analysis
2.4.4 P&G Product and Services
2.4.5 P&G Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 PaxVax
2.5.1 PaxVax Details
2.5.2 PaxVax Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 PaxVax SWOT Analysis
2.5.4 PaxVax Product and Services
2.5.5 PaxVax Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson Product and Services
2.6.4 Johnson & Johnson Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shanghai United Cell
2.7.1 Shanghai United Cell Details
2.7.2 Shanghai United Cell Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Shanghai United Cell Product and Services
2.7.4 Shanghai United Cell Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Valneva
2.8.1 Valneva Details
2.8.2 Valneva Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Valneva Product and Services
2.8.4 Valneva Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Immuron
2.9.1 Immuron Details
2.9.2 Immuron Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Immuron Product and Services
2.9.4 Immuron Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Traveler’s Diarrhea Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Traveler’s Diarrhea Treatment Players Market Share
3.2.2 Top 10 Traveler’s Diarrhea Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Traveler’s Diarrhea Treatment Revenue and Market Share by Regions
4.2 North America Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
5 North America Traveler’s Diarrhea Treatment Revenue by Countries
5.1 North America Traveler’s Diarrhea Treatment Revenue by Countries (2015-2020)
5.2 USA Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
6 Europe Traveler’s Diarrhea Treatment Revenue by Countries
6.1 Europe Traveler’s Diarrhea Treatment Revenue by Countries (2015-2020)
6.2 Germany Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
6.4 France Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Countries
7.1 Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Countries (2015-2020)
7.2 China Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
7.5 India Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
8 South America Traveler’s Diarrhea Treatment Revenue by Countries
8.1 South America Traveler’s Diarrhea Treatment Revenue by Countries (2015-2020)
8.2 Brazil Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Traveler’s Diarrhea Treatment by Countries
9.1 Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Traveler’s Diarrhea Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Traveler’s Diarrhea Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Traveler’s Diarrhea Treatment Market Forecast by Type (2019-2024)
10.3 Immunization Revenue Growth Rate (2015-2025)
10.4 Non-antibiotic Agents Revenue Growth Rate (2015-2025)
10.5 Antibiotics Revenue Growth Rate (2015-2025)
10.6 Anti-Motility Agents Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Traveler’s Diarrhea Treatment Market Segment by Application
11.1 Global Traveler’s Diarrhea Treatment Revenue Market Share by Application (2015-2020)
11.2 Traveler’s Diarrhea Treatment Market Forecast by Application (2019-2024)
11.3 Adult Traveler’s Diarrhea Revenue Growth (2015-2020)
11.4 Children Traveler’s Diarrhea Revenue Growth (2015-2020)
12 Global Traveler’s Diarrhea Treatment Market Size Forecast (2021-2025)
12.1 Global Traveler’s Diarrhea Treatment Market Size Forecast (2021-2025)
12.2 Global Traveler’s Diarrhea Treatment Market Forecast by Regions (2021-2025)
12.3 North America Traveler’s Diarrhea Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Traveler’s Diarrhea Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Traveler’s Diarrhea Treatment Revenue Market Forecast (2021-2025)
12.6 South America Traveler’s Diarrhea Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Traveler’s Diarrhea Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Traveler's Diarrhea Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Traveler's Diarrhea Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Traveler's Diarrhea Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Traveler's Diarrhea Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Traveler's Diarrhea Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Salix Pharmaceuticals Corporate Information, Location and Competitors
Table 7. Salix Pharmaceuticals Traveler's Diarrhea Treatment Major Business
Table 8. Salix Pharmaceuticals Traveler's Diarrhea Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Salix Pharmaceuticals SWOT Analysis
Table 10. Salix Pharmaceuticals Traveler's Diarrhea Treatment Product and Solutions
Table 11. Salix Pharmaceuticals Traveler's Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Livzon Corporate Information, Location and Competitors
Table 13. Livzon Traveler's Diarrhea Treatment Major Business
Table 14. Livzon Traveler's Diarrhea Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Livzon SWOT Analysis
Table 16. Livzon Traveler's Diarrhea Treatment Product and Solutions
Table 17. Livzon Traveler's Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Otsuka Pharma Corporate Information, Location and Competitors
Table 19. Otsuka Pharma Traveler's Diarrhea Treatment Major Business
Table 20. Otsuka Pharma Traveler's Diarrhea Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Otsuka Pharma SWOT Analysis
Table 22. Otsuka Pharma Traveler's Diarrhea Treatment Product and Solutions
Table 23. Otsuka Pharma Traveler's Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. P&G Corporate Information, Location and Competitors
Table 25. P&G Traveler's Diarrhea Treatment Major Business
Table 26. P&G Traveler's Diarrhea Treatment Total Revenue (USD Million) (2017-2018)
Table 27. P&G SWOT Analysis
Table 28. P&G Traveler's Diarrhea Treatment Product and Solutions
Table 29. P&G Traveler's Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. PaxVax Corporate Information, Location and Competitors
Table 31. PaxVax Traveler's Diarrhea Treatment Major Business
Table 32. PaxVax Traveler's Diarrhea Treatment Total Revenue (USD Million) (2017-2018)
Table 33. PaxVax SWOT Analysis
Table 34. PaxVax Traveler's Diarrhea Treatment Product and Solutions
Table 35. PaxVax Traveler's Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Johnson & Johnson Corporate Information, Location and Competitors
Table 37. Johnson & Johnson Traveler's Diarrhea Treatment Major Business
Table 38. Johnson & Johnson Traveler's Diarrhea Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Johnson & Johnson SWOT Analysis
Table 40. Johnson & Johnson Traveler's Diarrhea Treatment Product and Solutions
Table 41. Johnson & Johnson Traveler's Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Shanghai United Cell Corporate Information, Location and Competitors
Table 43. Shanghai United Cell Traveler's Diarrhea Treatment Major Business
Table 44. Shanghai United Cell Traveler's Diarrhea Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Shanghai United Cell SWOT Analysis
Table 46. Shanghai United Cell Traveler's Diarrhea Treatment Product and Solutions
Table 47. Shanghai United Cell Traveler's Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Valneva Corporate Information, Location and Competitors
Table 49. Valneva Traveler's Diarrhea Treatment Major Business
Table 50. Valneva Traveler's Diarrhea Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Valneva SWOT Analysis
Table 52. Valneva Traveler's Diarrhea Treatment Product and Solutions
Table 53. Valneva Traveler's Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Immuron Corporate Information, Location and Competitors
Table 55. Immuron Traveler's Diarrhea Treatment Major Business
Table 56. Immuron Traveler's Diarrhea Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Immuron SWOT Analysis
Table 58. Immuron Traveler's Diarrhea Treatment Product and Solutions
Table 59. Immuron Traveler's Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Traveler's Diarrhea Treatment Revenue (Million USD) by Players (2015-2020)
Table 61. Global Traveler's Diarrhea Treatment Revenue Share by Players (2015-2020)
Table 62. Global Traveler's Diarrhea Treatment Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Traveler's Diarrhea Treatment Revenue Market Share by Regions (2015-2020)
Table 64. North America Traveler's Diarrhea Treatment Revenue by Countries (2015-2020)
Table 65. North America Traveler's Diarrhea Treatment Revenue Market Share by Countries (2015-2020)
Table 66. Europe Traveler's Diarrhea Treatment Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Traveler's Diarrhea Treatment Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Traveler's Diarrhea Treatment Revenue by Countries (2015-2020)
Table 69. South America Traveler's Diarrhea Treatment Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Traveler's Diarrhea Treatment Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Traveler's Diarrhea Treatment Revenue Market Share by Countries (2015-2020)
Table 72. Global Traveler's Diarrhea Treatment Revenue (Million USD) by Type (2015-2020)
Table 73. Global Traveler's Diarrhea Treatment Revenue Share by Type (2015-2020)
Table 74. Global Traveler's Diarrhea Treatment Revenue Forecast by Type (2021-2025)
Table 75. Global Traveler's Diarrhea Treatment Revenue by Application (2015-2020)
Table 76. Global Traveler's Diarrhea Treatment Revenue Share by Application (2015-2020)
Table 77. Global Traveler's Diarrhea Treatment Revenue Forecast by Application (2021-2025)
Table 78. Global Traveler's Diarrhea Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Traveler's Diarrhea Treatment Picture
Figure 2. Global Traveler's Diarrhea Treatment Revenue Market Share by Type in 2019
Figure 3. Immunization Picture
Figure 4. Non-antibiotic Agents Picture
Figure 5. Antibiotics Picture
Figure 6. Anti-Motility Agents Picture
Figure 7. Other Picture
Figure 8. Traveler's Diarrhea Treatment Revenue Market Share by Application in 2019
Figure 9. Adult Traveler's Diarrhea Picture
Figure 10. Children Traveler's Diarrhea Picture
Figure 11. Global Traveler's Diarrhea Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Traveler's Diarrhea Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Traveler's Diarrhea Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Traveler's Diarrhea Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Traveler's Diarrhea Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Traveler's Diarrhea Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Traveler's Diarrhea Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Traveler's Diarrhea Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Traveler's Diarrhea Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Traveler's Diarrhea Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Traveler's Diarrhea Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Traveler's Diarrhea Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Traveler's Diarrhea Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Traveler's Diarrhea Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Traveler's Diarrhea Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Traveler's Diarrhea Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Traveler's Diarrhea Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Traveler's Diarrhea Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Traveler's Diarrhea Treatment Revenue Market Share by Countries in 2019
Figure 44. China Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Traveler's Diarrhea Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Traveler's Diarrhea Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Traveler's Diarrhea Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Traveler's Diarrhea Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Traveler's Diarrhea Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Traveler's Diarrhea Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Traveler's Diarrhea Treatment Revenue Share by Type in 2019
Figure 61. Global Traveler's Diarrhea Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Immunization Revenue Growth Rate (2015-2020)
Figure 63. Global Non-antibiotic Agents Revenue Growth Rate (2015-2020)
Figure 64. Global Antibiotics Revenue Growth Rate (2015-2020)
Figure 65. Global Anti-Motility Agents Revenue Growth Rate (2015-2020)
Figure 66. Global Other Revenue Growth Rate (2015-2020)
Figure 67. Global Traveler's Diarrhea Treatment Revenue Share by Application (2015-2020)
Figure 68. Global Traveler's Diarrhea Treatment Revenue Share by Application in 2019
Figure 69. Global Traveler's Diarrhea Treatment Market Share Forecast by Application (2021-2025)
Figure 70. Global Adult Traveler's Diarrhea Revenue Growth Rate (2015-2020)
Figure 71. Global Children Traveler's Diarrhea Revenue Growth Rate (2015-2020)
Figure 72. Global Traveler's Diarrhea Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Traveler's Diarrhea Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Traveler's Diarrhea Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Traveler's Diarrhea Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Traveler's Diarrhea Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Traveler's Diarrhea Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Traveler's Diarrhea Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Traveler's Diarrhea Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
皮膚・軟部組織感染治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Skin and Soft Tissue Infection Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …- 多嚢胞性卵巣症候群治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Polycystic Ovarian Syndrome Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.7% in the forecast period of 2020 to 2025 and will expected to reach USD 3557.8 million by 2025, from USD 3196.5 million in 2019. Th…
- 孤児肺疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Orphan Lung Diseases Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Orphan Lung Di…
- 鳥インフルエンザ治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bird Flu Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bird Flu Treatment market …
- レット症候群治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rett Syndrome Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…